Normalization of obesity-associated insulin resistance through immunotherapy

Nature Medicine

Volumn 15, Issue 8, 2009, Pages 921-929

  Winer, Shawn ^a   Chan, Yin ^a   Paltser, Geoffrey ^a   Truong, Dorothy ^a   Tsui, Hubert ^a   Bahrami, Jasmine ^b   Dorfman, Ruslan ^a   Wang, Yongqian ^a   Zielenski, Julian ^a   Mastronardi, Fabrizio ^a   Maezawa, Yuko ^a   Drucker, Daniel J ^b   Engleman, Edgar ^c   Winer, Daniel ^c   Dosch, H Michael ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN FRAGMENT; INSULIN; LEPTIN; RAG1 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CARBON DIOXIDE EXCRETION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL SIZE; CONTROLLED STUDY; DISEASE COURSE; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HELPER CELL; IMMUNOTHERAPY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID DIET; LUNG GAS EXCHANGE; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN; TH2 CELL; WEIGHT GAIN;

ADIPOSE TISSUE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; GLUCOSE; HOMEODOMAIN PROTEINS; HOMEOSTASIS; IMMUNOTHERAPY; INSULIN RESISTANCE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, OBESE; OBESITY;

MUS;

EID: 68349137821     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2001     Document Type: Article

References (46)

1. Kahn, S.E., Hull, R.L. & Utzschneider, K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-846 (2006).
2. Déspres, J.P. & Lemieux, I. Abdominal obesity and metabolic syndrome. Nature 444, 881-887 (2006).
3. Dahabreh, I.J. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone. Clin. Trials 5, 116-120 (2008).
4. Hanson, R.L., Imperatore, G., Bennett, P.H. & Knowler, W.C. Components of the 'metabolic syndrome' and incidence of type 2 diabetes. Diabetes 51, 3120-3127 (2002).
5. Hotamisligil, G.S. Inflammation and metabolic disorders. Nature 444, 860-867 (2006).
6. Kim, J.Y. et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 117, 2621-2637 (2007).
7. Furuhashi, M. et al. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J. Clin. Invest. 118, 2640-2650 (2008).
8. Kanda, H. et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116, 1494-1505 (2006).
9. Yuan, M. et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ. Science 293, 1673-1677 (2001).
10. Weisberg, S.P. et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116, 115-124 (2006).
11. Odegaard, J.I. et al. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 447, 1116-1120 (2007).
12. + regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. USA 104, 19446-19451 (2007).
13. Martinez, F.O., Sica, A., Mantovani, A. & Locati, M. Macrophage activation and polarization. Front. Biosci. 13, 453-461 (2008).
14. Cintra, D.E. et al. Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. J. Hepatol. 48, 628-637 (2008).
15. Lumeng, C.N., Bodzin, J.L. & Saltiel, A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184 (2007).
16. Rausch, M.E., Weisberg, S., Vardhana, P. & Tortoriello, D.V. Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int. J. Obes. (Lond.) 32, 451-463 (2008).
17. Kintscher, U. et al. T-lymphocyte infiltration in visceral adipose tissue, a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler. Thromb. Vasc. Biol. 28, 1304-1310 (2008).
18. Wu, H. et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 115, 1029-1038 (2007).
19. Baker, F.J., Lee, M., Chien, Y.H. & Davis, M.M. Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice. Proc. Natl. Acad. Sci. USA 99, 9374-9379 (2002).
20. Turner, S.J., Doherty, P.C., McCluskey, J. & Rossjohn, J. Structural determinants of T-cell receptor bias in immunity. Nat. Rev. Immunol. 6, 883-894 (2006).
21. Oksenberg, J.R. et al. Limited heterogeneity of rearranged T-cell receptor V α transcripts in brains of multiple sclerosis patients. Nature 345, 344-346 (1990).
22. Jenkins, R.N., Nikaein, A., Zimmermann, A., Meek, K. & Lipsky, P.E. Tcell receptor V β gene bias in rheumatoid arthritis. J. Clin. Invest. 92, 2688-2701 (1993).
23. Belghith, M. et al. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 9, 1202-1208 (2003).
24. Caspar-Bauguil, S. et al. Adipose tissues as an ancestral immune organ: site-specific change in obesity. FEBS Lett. 579, 3487-3492 (2005).
25. H1 lineage commitment. Cell 100, 655-669 (2000).
26. Barnden, M.J., Allison, J., Heath, W.R. & Carbone, F.R. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76, 34-40 (1998).
27. Padovan, E. et al. Expression of two T cell receptor α chains: dual receptor T cells. Science 262, 422-424 (1993).
28. Fontenot, J.D., Rasmussen, J.P., Gavin, M.A. & Rudensky, A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142-1151 (2005).
29. Awasthi, A. et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8, 1380-1389 (2007).
30. H2 cytokine profile. J. Immunol. 164, 3047-3055 (2000).
31. H2 response and IgE class switching in mice with disrupted Steffi gene. Nature 380, 630-633 (1996).
32. H2 cells. Immunity 4, 313-319 (1996).
33. + Tregs. J. Clin. Invest. 115, 2904-2913 (2005).
34. Chatenoud, L. & Bluestone, J.A. CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat. Rev. Immunol. 7, 622-632 (2007).
35. Alegre, M. et al. Acute toxicity of anti-CD3 monoclonal antibody in mice: a model for OKT3 first dose reactions. Transplant. Proc. 22, 1920-1921 (1990).
36. Alegre, M. et al. Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor. Eur. J. Immunol. 20, 707-710 (1990).
37. Claycombe, K., King, L.E. & Fraker, P.J. A role for leptin in sustaining lymphopoiesis and myelopoiesis. Proc. Natl. Acad. Sci. USA 105, 2017-2021 (2008).
38. Zeyda, M. & Stulnig, T.M. Adipose tissue macrophages. Immunol. Lett. 112, 61-67 (2007).
39. H1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ. Res. 103, 467-476 (2008).
40. Korn, T. et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13, 423-431 (2007).
41. Herald, K.C. et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346, 1692-1698 (2002).
42. Steffens, S. & Mach, F. Adiponectin and adaptive immunity: linking the bridge from obesity to atherogenesis. Circ. Res. 102, 140-142 (2008).
43. Macia, L. et al. Impairment of dendritic cell functionality and steady-state number in obese mice. J. Immunol. 177, 5997-6006 (2006).
44. Kumpers, P. et al. Leptin is a coactivator of TGF-β in unilateral ureteral obstructive kidney disease. Am. J. Physiol. Renal Physiol. 293, F1355-F1362 (2007).
45. Perruche, S. et al. CD3-specific antibody-induced immune tolerance involves transforming growth factor-β from phagocytes digesting apoptotic T cells. Nat. Med. 14, 528-535 (2008).
46. Strissel, K.J. et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 56, 2910-2918 (2007).